AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,450.00p
   
  • Change Today:
    -176.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.67m
  • Volume: 1,733,922
  • Market Cap: £162,045m
  • RiskGrade: 123

Latest ShareCast News

Berenberg raises target price on AstraZeneca

By Iain Gilbert

Date: Wednesday 09 Jul 2025

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker AstraZeneca from £140 to £142 per share on Wednesday, citing "strong pipeline readouts" which were yet to be reflected in its share price.

Sunday newspaper round-up: Trade, AstraZeneca, Tax hikes

By Alexander Bueso

Date: Sunday 06 Jul 2025

(Sharecast News) - Brussels is heading into a critical week, with just two to go to clinch a trade agreement with the US or face a 50% levy on its exports. At stake are €1.6trn in transatlantic trade. Germany is down as favouring a quick deal akin to that inked by the UK so as to avoid a full-blown trade war. Paris on the other hand believes that the EU should hold out if too quick a deal is "imbalanced" - Guardian

London close: FTSE finishes flat ahead of Trump tariff deadline

By Josh White

Date: Friday 04 Jul 2025

(Sharecast News) - London stocks ended Thursday little changed at the top tier but weaker further down the board, as investors weighed fresh economic data and cautious sentiment ahead of Donald Trump's 9 July tariff deadline next week.

AstraZeneca's Imfinzi gets EU green light 04-Jul-2025 ShareCast
AstraZeneca's Datroway gets green light from FDA 24-Jun-2025 ShareCast
AstraZeneca launches strategic research collabor... 13-Jun-2025 ShareCast
AstraZeneca's Calquence receives European Commis... 06-Jun-2025 ShareCast
EU recommends AstraZeneca bladder cancer treatme... 27-May-2025 ShareCast
London close: Stocks finish choppy week in the b... 16-May-2025 ShareCast
London close: Stocks rally on US-China tariff deal 12-May-2025 ShareCast
Pharma stocks slide as Trump threatens price cut... 12-May-2025 ShareCast
Sunday newspaper round-up: US-China, Aerospace, ... 11-May-2025 ShareCast
London close: FTSE snaps 16-day win streak ahead... 07-May-2025 ShareCast
GSK, AstraZeneca slide after FDA unveils new vac... 07-May-2025 ShareCast
AstraZeneca receives 'positive high-level result... 07-May-2025 ShareCast
AstraZeneca's Calquence gets Europe approval for... 06-May-2025 ShareCast
AstraZeneca's Breztri meets all primary endpoint... 02-May-2025 ShareCast
AstraZeneca reports strong first quarter 29-Apr-2025 ShareCast
AstraZeneca receives positive Phase III trial re... 22-Apr-2025 ShareCast
London close: Stocks fall as China retaliates to... 09-Apr-2025 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,450.00p
Change Today -176.00p
% Change -1.66 %
52 Week High 13,276.00
52 Week Low 9,667.00
Volume 1,733,922
Shares Issued 1,550.67m
Market Cap £162,045m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.72% below the market average93.72% below the market average93.72% below the market average93.72% below the market average93.72% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Price Trend
28.36% below the market average28.36% below the market average28.36% below the market average28.36% below the market average28.36% below the market average
26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average
Income
60.22% below the market average60.22% below the market average60.22% below the market average60.22% below the market average60.22% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
87.25% above the market average87.25% above the market average87.25% above the market average87.25% above the market average87.25% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 4
Sell 0
Strong Sell 1
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 11-Jul-2025

Time Volume / Share Price
16:27 13 @ 10,440.00p
16:27 3 @ 10,440.00p
16:27 0 @ 10,440.00p
16:27 0 @ 10,440.00p
16:15 0 @ 10,448.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page